Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families
Year: 2006
Type: article
Study design: Observational Study
Source: Movement Disorders
DOI: 10.1002/mds.21180
Authors: Lianna Ishihara, Rachel A. Gibson, Liling Warren, Rim Amouri, Kelly Lyons, Catherine Wielinski, Christine Hunter, Jina E. Swartz, Ramu Elango, P. Anthony Akkari, David Leppert, Linda Surh, Kevin H. Reeves, Siwan Thomas, Leigh Ragone, Nobutaka Hattori, Rajesh Pahwa, Joseph Jankovic, Martha Nance, Alan Freeman, Neziha Gouider‐Khouja, Mounir Kefi, Mourad Zouari, Samia Ben Sassi, Samia Ben Yahmed, Ghada El Euch‐Fayeche, Lefkos Middleton, David J. Burn, Ray L. Watts, Faycal Hentati
Institutions: University of Cambridge, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States), Hôpital La Rabta, National Institute of Neurology Mongi-Ben Hamida, University of Kansas Medical Center, Baylor College of Medicine, Juntendo University, Emory University, Newcastle upon Tyne Hospital, University of Alabama at Birmingham, UAB Medicine
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2003198613